APA (7th ed.) Citation

Conte, B., Martini, V., Alsati, R., Boldorini, R., Gobbato, S., Negrini, L., . . . Gennari, A. (2024). 141P Circulating immune cells predict immunotherapy benefit in patients with triple negative breast cancer: Preliminary results from the IRIS study. Annals of Oncology, 35, S271. https://doi.org/10.1016/j.annonc.2024.08.149

Chicago Style (17th ed.) Citation

Conte, B., et al. "141P Circulating Immune Cells Predict Immunotherapy Benefit in Patients with Triple Negative Breast Cancer: Preliminary Results from the IRIS Study." Annals of Oncology 35 (2024): S271. https://doi.org/10.1016/j.annonc.2024.08.149.

MLA (9th ed.) Citation

Conte, B., et al. "141P Circulating Immune Cells Predict Immunotherapy Benefit in Patients with Triple Negative Breast Cancer: Preliminary Results from the IRIS Study." Annals of Oncology, vol. 35, 2024, p. S271, https://doi.org/10.1016/j.annonc.2024.08.149.